Literature DB >> 15906573

Correlation of cell-mediated immunity against porcine reproductive and respiratory syndrome virus with protection against reproductive failure in sows during outbreaks of porcine reproductive and respiratory syndrome in commercial herds.

James E Lowe1, Robert Husmann, Lawrence D Firkins, Federico A Zuckermann, Tony L Goldberg.   

Abstract

OBJECTIVE: To determine whether cell-mediated immunity against porcine reproductive and respiratory syndrome (PRRS) virus is correlated with protection against reproductive failure in sows during clinical outbreaks of PRRS in commercial herds.
DESIGN: Outbreak investigation in 4 swine breeding herds. ANIMALS: 97 sows. PROCEDURES: On each farm, blood samples were collected from sows with clinical signs (abortion or increased fetal death; case sows) and from clinically normal sows (control sows). The intensity of the cell-mediated immune (CMI) response was determined by use of an interferon-gamma enzyme-linked immunospot (ELISPOT) assay. Multiple logistic regression analyses and t tests were used to compare ELISPOT assay values between case and control sows. Multiple linear regression was used to investigate associations between cell-mediated immunity and the magnitude of clinical signs.
RESULTS: In 2 farms, case sows had lower ELISPOT assay values than control sows. A negative association between the intensity of the CMI response and the number of pigs born dead per litter was detected on 1 farm. In 1 farm, no association was detected between the intensity of the CMI response and protection against reproductive failure. CONCLUSIONS AND CLINICAL RELEVANCE: Evidence that a strong CMI response was correlated with protection against clinical PRRS was detected in 3 of 4 farms. However, farms and sows within farms varied considerably in their immune responsiveness and in the degree to which they were protected clinically. Increasing cell-mediated immunity within infected herds has the potential to decrease clinical reproductive disease, but only if the sources of intra- and interfarm variation in the intensity of cell-mediated immunity to PRRS virus can be identified.

Entities:  

Mesh:

Year:  2005        PMID: 15906573     DOI: 10.2460/javma.2005.226.1707

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  26 in total

1.  Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus.

Authors:  Hyun-Jeong Jeong; Young-Jo Song; Sang-Won Lee; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Gun-Woo Ha; Jin-Sik Oh; Youn-Kyoung Oh; In-Soo Choi
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

2.  A modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine protects late-term pregnancy gilts against a heterologous PRRSV-2 challenge.

Authors:  Siyeon Yang; Ikjae Kang; Hyejean Cho; Taehwan Oh; Kee Hwan Park; Kyung-Duk Min; Chanhee Chae
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

3.  Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigs.

Authors:  Chul Han An; Salik Nazki; Sung-Chul Park; Yu Jeong Jeong; Ju Huck Lee; Su-Jin Park; Amina Khatun; Won-Il Kim; Youn-Il Park; Jae Cheol Jeong; Cha Young Kim
Journal:  Planta       Date:  2018-01-08       Impact factor: 4.116

4.  Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection.

Authors:  Ivan Díaz; Mariona Gimeno; Laila Darwich; Nuria Navarro; Liudmila Kuzemtseva; Sergio López; Ivan Galindo; Joaquim Segalés; Margarita Martín; Joan Pujols; Enric Mateu
Journal:  Vet Res       Date:  2012-04-19       Impact factor: 3.683

5.  Cytokine profiles in pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus and relationships with viral load and fetal outcome.

Authors:  Andrea Ladinig; Joan K Lunney; Carlos J H Souza; Carolyn Ashley; Graham Plastow; John C S Harding
Journal:  Vet Res       Date:  2014-12-06       Impact factor: 3.683

6.  Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation.

Authors:  Kiwon Han; Hwi Won Seo; Changhoon Park; Chanhee Chae
Journal:  Vet Res       Date:  2014-02-02       Impact factor: 3.683

7.  Induction of interleukin-10 is dependent on p38 mitogen-activated protein kinase pathway in macrophages infected with porcine reproductive and respiratory syndrome virus.

Authors:  Jun Hou; Lianghai Wang; Rong Quan; Yi Fu; Hexiao Zhang; Wen-hai Feng
Journal:  Virol J       Date:  2012-08-21       Impact factor: 4.099

8.  Immunogenic and protective properties of GP5 and M structural proteins of porcine reproductive and respiratory syndrome virus expressed from replicating but nondisseminating adenovectors.

Authors:  Elodie Roques; Aurélie Girard; Marie-Claude St-Louis; Bernard Massie; Carl A Gagnon; Martin Lessard; Denis Archambault
Journal:  Vet Res       Date:  2013-03-11       Impact factor: 3.683

9.  Control of porcine reproductive and respiratory syndrome (PRRS) through genetic improvements in disease resistance and tolerance.

Authors:  Raymond R R Rowland; Joan Lunney; Jack Dekkers
Journal:  Front Genet       Date:  2012-12-14       Impact factor: 4.599

10.  Construction and immunogenicity of DNA vaccines encoding fusion protein of porcine IFN- λ 1 and GP5 gene of porcine reproductive and respiratory syndrome virus.

Authors:  Luping Du; Bin Li; Kongwang He; Haibin Zhang; Kehe Huang; Shaobo Xiao
Journal:  Biomed Res Int       Date:  2013-12-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.